Mu Wenxin, Li Shanshan, Lu Qian, Wang Juan, Tao Xiaoan
Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Guangdong Provincial Clinical Research Center of Oral Diseases, Sun Yat-sen University, Guangzhou, China.
Front Oral Health. 2024 Dec 18;5:1458329. doi: 10.3389/froh.2024.1458329. eCollection 2024.
Burning mouth syndrome (BMS) is a chronic orofacial pain disorder that seriously affects quality of life of patients. In recent years, Low-level laser therapy (LLLT) has been regarded as an important innovation in pain management, but there is insufficient evidence of its effectiveness in patients with painful BMS. This study aimed to evaluate the efficacy of LLLT for immediate pain relief due to BMS.
This retrospective study included 94 BMS patients that were treated with an intraoral semiconductor laser (635 nm, 100 mW/cm). Pain was self-assessed before and immediately after LLLT sessions using a 0-to-10 visual analogue scale (VAS). Paired-samples -test and multivariable binary logistic regression were used to analyze overall efficacy and its influencing factors.
After standardized LLLT session, 71.3% of patients reported an immediate pain decrease. Compared to pre-LLLT treatment, the VAS immediately post-LLLT was significantly reduced ( < 0.001). Mean post-LLLT VAS reduction was 2.2 ± 2.0, equivalent to 39.9% of the initial pain level. Meanwhile, low VAS before treatment, history of smoking or alcohol, xerostomia, and gingival lesions correlated with worse LLLT efficacy. There were no side effects or adverse reactions were noticed by the practitioner or reported by the patients.
LLLT may provide non-pharmacological, non-invasive, side-effect-free, and rapid pain relief for painful BMS patients. No baseline characteristics affecting overall efficiency were found except for VAS before treatment, history of smoking or alcohol, xerostomia, and gingival lesions.
灼口综合征(BMS)是一种慢性口腔面部疼痛疾病,严重影响患者的生活质量。近年来,低强度激光疗法(LLLT)被视为疼痛管理方面的一项重要创新,但尚无充分证据表明其对疼痛性BMS患者有效。本研究旨在评估LLLT对BMS所致即刻疼痛缓解的疗效。
本回顾性研究纳入了94例接受口腔内半导体激光(635 nm,100 mW/cm)治疗的BMS患者。在LLLT治疗前和治疗后即刻,患者使用0至10的视觉模拟量表(VAS)进行自我疼痛评估。采用配对样本t检验和多变量二元逻辑回归分析总体疗效及其影响因素。
经过标准化的LLLT治疗后,71.3%的患者报告疼痛即刻减轻。与LLLT治疗前相比,LLLT治疗后即刻的VAS显著降低(P < 0.001)。LLLT治疗后VAS平均降低2.2±2.0,相当于初始疼痛水平的39.9%。同时,治疗前VAS较低、有吸烟或饮酒史、口干症以及牙龈病变与LLLT疗效较差相关。从业者未注意到副作用或不良反应,患者也未报告。
LLLT可为疼痛性BMS患者提供非药物、非侵入性、无副作用且快速的疼痛缓解。除了治疗前VAS、吸烟或饮酒史、口干症以及牙龈病变外,未发现影响总体疗效的基线特征。